1. Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience. (13th March 2021) Authors: Jurgensen‐Rauch, Amanda; Gibbs, Suzanne; Farrell, Maresa; Aries, James; Grantham, Marianne; Eccersley, Lydia; Gribben, John; Hallam, Simon; Oakervee, Heather; Cavenagh, Jamie; Davies, Jeff; Sive, Jonathan Journal: British journal of haematology Issue: Volume 193:Number 2(2021) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant. (April 2015) Authors: Uddin, Shab; Russell, Pippa; Farrell, Maresa; Davy, Barbara; Taylor, Joe; Agrawal, Samir G. Journal: Therapeutic advances in hematology Issue: Volume 6:Number 2(2015:Apr.) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗